Tony Bark@pawb.social to science@lemmy.worldEnglish · edit-217 päivää sittenScientists discover how to reactivate cancer’s molecular “kill switch” at the Jackson Laboratorywww.jax.orgexternal-linkmessage-square7fedilinkarrow-up1152arrow-down13
arrow-up1149arrow-down1external-linkScientists discover how to reactivate cancer’s molecular “kill switch” at the Jackson Laboratorywww.jax.orgTony Bark@pawb.social to science@lemmy.worldEnglish · edit-217 päivää sittenmessage-square7fedilink
minus-squareMaeve@kbin.earthlinkfedilinkarrow-up18·17 päivää sittenWill it be accessible to everyone? I read it. Just musing.
minus-squareScolding7300@lemmy.worldlinkfedilinkEnglisharrow-up8·17 päivää sittenOnly for the good guys
minus-squareDharma Curious (he/him)@slrpnk.netlinkfedilinkEnglisharrow-up7·17 päivää sittenProbably not in the US, but hopefully it’ll at least be accessible for the insured…
minus-squareearphone843@sh.itjust.workslinkfedilinkEnglisharrow-up4·17 päivää sittenIt really depends on if production can scale.
minus-squareTony Bark@pawb.socialOPlinkfedilinkEnglisharrow-up2·17 päivää sittenI hope so. It is RNA-based.
minus-squareGentriFriedRice@lemmy.worldlinkfedilinkEnglisharrow-up3·17 päivää sittenWell the RNA bit is the easy part. Finding a way to target cancer cells with gene splicing gets trickier
Will it be accessible to everyone? I read it. Just musing.
Only for the good guys
Probably not in the US, but hopefully it’ll at least be accessible for the insured…
It really depends on if production can scale.
I hope so. It is RNA-based.
Well the RNA bit is the easy part. Finding a way to target cancer cells with gene splicing gets trickier